Interventional Techniques for Cancer Pain Management

Clinical Oncology

Volumn 23, Issue 6, 2011, Pages 407-417

  De Courcy, J G ^a  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Anaesthetic techniques; Cancer pain; Epidural; Intrathecal; Neuraxial techniques; Vertebroplasty

Indexed keywords

ALCOHOL; ANALGESIC AGENT; BACLOFEN; BUPIVACAINE; CLONIDINE; DIAMORPHINE; FENTANYL; HYDROMORPHONE; KETAMINE; LOCAL ANESTHETIC AGENT; MIDAZOLAM; MORPHINE; OMEGA CONOTOXIN MVIIA; OPIATE; STEROID; SUFENTANIL;

ANALGESIA; ARTICLE; BONE METASTASIS; BONE PAIN; CANCER PAIN; CELIAC PLEXUS; CORDOTOMY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG PENETRATION; ENDOCRINE DISEASE; EPIDURAL ANESTHESIA; GRANULOMA; HUMAN; LOCAL ANESTHESIA; NEUROLYSIS; NEUROPATHIC PAIN; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; SPASTICITY; SPINAL ANESTHESIA; SPINAL CORD STIMULATION; SPLANCHNIC NERVE; UNSPECIFIED SIDE EFFECT; URINE RETENTION;

ANALGESIA; HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT;

EID: 79959739212     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.04.003     Document Type: Article

References (135)

1. Zech D.F.J., Grond S., Lynch J., et al. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 1995, 63:65-76.
2. Meuser T., Pietruck C., Radbruch L., et al. Symptoms during cancer pain treatment following WHO guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001, 93(3):247-257.
3. Breivik H., Collett B., Ventafridda V., Cohen R., Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006, 10(4):287-333.
4. Valeberg B.T., Rustoen T., Bjordal K., Hanestad B.R., Paul S., Miaskowski C. Self-reported prevalence, etiology and characteristics of pain in oncology outpatients. J Pain 2008, 12(5):582-590.
5. Breivik H., Cherny N., Collett B., et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009, 20(8):1420-1433.
6. Miguel R. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder?. Cancer Control 2000, 7:149-156.
7. Linklater G.T., Leng M.E., Tiernan E.J., Lee M.A., Chambers W.A. Pain management services in palliative care: a national survey. Palliat Med 2002, 16:435-439.
8. Kay S., Husbands E., Antrobus J.H., Munday D. Provision for advanced pain management techniques in adult palliative care: a national survey of anaesthetic pain specialists. Palliat Med 2007, 21(4):279-284.
9. National Institute for Health and Clinical Excellence. NICE guidance: improving supportive and palliative care for adults with cancer. Section 9.29. Available at: http://www.nice.org.uk.
10. Scottish Intercollegiate Guidelines Network. Guideline 106. Control of pain in adults with cancer - a national clinical guideline, November 2008. Available at: http://www.sign.ac.uk.
11. Eidelman A., White T., Swarm R.A. Interventional therapies for cancer pain management: important adjuvants to systemic analgesics. J Natl Comp Cancer Network 2007, 5:753-760.
12. Deer T., Krames E.S., Hassenbusch S.J., et al. Polyanalgesic Consensus Conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2007, 10(4):300-327.
13. Chambers W.A. Nerve blocks in palliative care. Br J Anaesth 2008, 101(1):95-100.
14. The use of drugs beyond licence in palliative care and pain management. A position statement prepared on behalf of the Association for Palliative Medicine and the British Pain Society 2005, APM and BPS, London.
15. Dickenson A.H. Spinal cord pharmacology of pain. Br J Anaesth 1995, 75:193-200.
16. Krames E. Practical issues when using neuraxial infusion. Oncology 1999, 13:37-44.
17. Wang J.K., Nauss L.A., Thomas J.E. Pain relief by intrathecally applied morphine in man. Anesthesiology 1979, 50:149-151.
18. Stearns L., Boortz-Marx R., Du Pen S., et al. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J Support Oncol 2005, 3(6):399-408.
19. Kedlaya D., Reynolds L., Waldman S. Epidural and intrathecal analgesia for cancer pain. Best Practice Res Clin Anaesthesiol 2002, 16(4):651-665.
20. Hassenbusch S.J., Portenoy R.K., Cousins M., et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery - report of an expert panel. J Pain Symptom Manage 2004, 27:540-563.
21. Williams J.E., Towlerton G., Louw G. Intrathecal pumps for chronic pain; systematic review. Health Technol Assess 2000, 4(32):1-65.
22. British Pain Society Intrathecal drug delivery for the management of pain and spasticity in adults; recommendations for best clinical practice 2008, British Pain Society London.
23. Gilmer-Hill H.S., Boggan J.E., Smith K.A., Wagner F.C. Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature. Surg Neurol 1999, 51(1):12-15.
24. Ballantyne J.C., Carwood C. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Cochrane Database System Rev 2005, Issue 2:Art. No. CD005178.
25. Smith T.J., Staats P.S., Deer T., et al. Randomised clinical trial of an implantable drug delivery system compared with comprehensive medical management of refractory cancer pain: impact on pain, drug related toxicity and survival. J Clin Oncol 2002, 20:4040-4049.
26. Smith T.J., Coyne P.J., Staats P.S., et al. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol 2005, 16:825-833.
27. Lillemoe K.D., Cameron J.L., Kaufman H.S., et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer: a prospective randomized trial. Ann Surg 1993, 217:447-457.
28. Dennis G.C., DeWitty R.L. Long-term intraventricular infusion of morphine for intractable pain in cancer of the head and neck. Neurosurgery 1990, 26:404.
29. Gupta A., Martindale T., Christo P.J. Intrathecal catheter granuloma associated with continuous sufentanil infusion. Pain Med 2010, 11:847-852.
30. Malone B.T., Beye R., Walker J. Management of pain in the terminally ill by administration of epidural narcotics. Cancer 1985, 55:438-440.
31. Baker L., Lee M., Regnard C., Crack L., Callin S. Evolving spinal analgesia practice in palliative care. Palliat Med 2004, 18:507-515.
32. Walker S.M., Goudas L.C., Cousins M.J., Carr D.B. Combination spinal analgesic chemotherapy: a systematic review. Anesth Analg 2002, 95:674-715.
33. Akerman B., Arwestrom E., Post C. Local anesthetics potentiate spinal morphine antinociception. Anesth Analg 1988, 67:943-948.
34. van Dongen R.T., Crul B.J., van Egmond J. Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. Clin J Pain 1999, 15(3):166-172.
35. Mercadente S. Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at home. J Pain Symptom Manage 1994, 9:201-207.
36. Johnson S.M., Saint John B.E., Dine A.P. Local anesthetics as antimicrobial agents: a review. Surg Infect 2008, 9:1096-2964.
37. Baker L., Balls J., Regnard C., Pridie A. Cervical intrathecal analgesia for head and neck/upper limb cancer pain: six case reports. Palliat Med 2007, 21:543-545.
38. Lundborg C., Dahm P., Nitescu P., Biber B. High intrathecal bupivacaine for severe pain in the head and neck. Acta Anaesthesiol Scand 2009, 53:908-913.
39. Mercadente S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 1999, 79:1-13.
40. Eisenach J.C., DuPen S., Dubois M., et al. Epidural clonidine analgesia for intractable cancer pain. Pain 1995, 61:391-399.
41. Benrath B., Scharbert G., Gustorff B., Adams H.-A., Kress H.G. Long-term intrathecal S(+)-ketamine in a patient with cancer-related neuropathic pain. Br J Anaesth 2005, 95:247.
42. Vranken J.H., Troost D., Wegener J.T., Kruis M.R., Van Der Vegt M.H. Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain. Pain 2005, 117:231-235.
43. Staats P., Yearwood T., Wallace M., et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS. JAMA 2004, 291:63-70.
44. Zuurmond W.W., Perez R.S., Loer S.A. New aspects in performing interventional techniques for chronic pain. Curr Opin Supp Palliat Care 2007, 1:132-136.
45. Bennett G., Serafini M., Burchiel K., et al. Evidence based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage 2000, 20:S12-S36.
46. Nitescu P., Applegren L., Lindler L. Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatments in advanced cancer pain. J Pain Symptom Manag 1990, 5:18-26.
47. Dahm P., Nitescu P., Applegren L., Curelaru I. Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory non malignant pain; a comparison between the epidural and intrathecal approach with externalized or implanted catheters and infusion pumps. Clin J Pain 1998, 14:4-16.
48. Crul B.J., Delhaas E.M. Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients: a review of 140 cases. Reg Anesth Pain Med 1991, 16(4):209-213.
49. Mueller-Schwefe G., Hassenbusch S.J., Reig E. Cost-effectiveness of intrathecal therapy for pain. Neuromodulation 1999, 2:247-257.
50. Erdine S., Talu G.K. Cost effectiveness of implantable devices versus tunneled catheters. Curr Rev Pain 1998, 2:157-162.
51. Bedder M.D., Burchiel J.K., Larson A. Cost analysis of two narcotic delivery systems. J Pain Symptom Manage 1991, 6:397-409.
52. Mercadante S. Neuraxial techniques for cancer pain: an opinion about unresolved therapeutic dilemmas. Reg Anesth Pain Med 1999, 24:74-83.
53. Rauck R.L., Cherry D., Boyer M.F., et al. Long-term intrathecal opioid therapy with a patient-activated implanted delivery system for the treatment of refractory cancer pain. J Pain 2003, 4:441-447.
54. Mercadente S., Arcuri E., Ferrera P., Villari P., Mangione S. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage 2005, 30:485-491.
55. Higginson I., Astin P., Dolan S. Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England. Palliat Med 1998, 12(5):353-363.
56. Gestin Y., Vainio A., Pegurier A. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer. Acta Anaesthesiol Scand 1997, 41(1):12-17.
57. Nitescu P., Sjoberg M., Appelgren L., Curelaru I. Complications of intrathecal opioids and bupivacaine in the treatment of 'refractory' cancer pain. Clin J Pain 1995, 11:45-62.
58. Smith H.S., Deer T.R., Staats P.S., et al. Intrathecal drug delivery. Pain Physician 2008, 11:S89-S104.
59. Staats P.S. Complications of intrathecal therapy. Pain Med 2008, 9(S1):S102-S107.
60. Myers J., Chan V., Jarvis V., Walker-Dilks C. Intraspinal techniques for pain management in cancer patients: a systematic review. Support Care Cancer 2010, 18:137-149.
61. Sjoberg M., Karlsson P.A., Vranken J.H., et al. Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. Anesthesiology 1992, 76:173-186.
62. Follett K.A., Naumann C.P. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 2000, 19:209-215.
63. Sloan P.A. The evolving role of interventional pain management in oncology. J Support Oncol 2004, 2(6):491-500. 503.
64. Aprili D., Bandschapp O., Rochlitz C., Urwyler A., Ruppen W. Serious complications associated with external intrathecal catheters used in cancer pain patients: a systematic review and meta-analysis. Anesthesiology 2009, 111(6):1346-1355.
65. Du Pen S.L., Peterson D.G., Williams A., et al. Infection during chronic epidural catheterization: diagnosis and treatment. Anesthesiology 1990, 73:905-909.
66. Ruppen W., Derry S., McQuay H., Moore R.A. Infection rates associated with epidural indwelling catheters for seven days or longer: systematic review and meta-analysis. BMC Palliat Care 2007, 6:3.
67. Holmfred A., Vikerfors T., Berggren L., Gupta A. Intrathecal catheters with subcutaneous port systems in patients with severe cancer-related pain managed out of hospital: the risk of infection. J Pain Symptom Manage 2006, 31:568-572.
68. Gentili M.E. Epidural fibrin glue injection stops postdural puncture headache in patient with long-term intrathecal catheterization. Reg Anesth Pain Med 2003, 28:70.
69. Cherry D.A., Gourlay D., Cousins M.J. Epidural mass associated with lack of efficacy of epidural morphine and undetectable CSF morphine concentrations. Pain 1986, 25:69-73.
70. Vranken J.H., Zuurmond W.W., de Lange J.J. Continuous brachial plexus block as treatment for the Pancoast syndrome. Clin J Pain 2000, 16(4):749.
71. Simpson K.H. Interventional techniques for pain management in palliative care. Medicine 2007, 36(2):72-74.
72. Linklater G.T., Chambers W.A. Persistent pain relief following epidural analgesia for cancer pain. Anaesthesia 2008, 63(10):1152.
73. Okell R.W., Brooks N.C. Persistent pain relief following interscalene analgesia for cancer pain. Anaesthesia 2009, 64:25-26.
74. Boys L., Peat S.J., Hanna M.H., Burn K. Audit of neural blockade for palliative care patients in an acute unit. Palliat Med 1993, 7:205-211.
75. Arner S., Lindblom U., Meyerson B., Molander C. Prolonged relief of neuralgia after regional anesthetic blocks. A call for further experimental and systematic clinical studies. Pain 1990, 43:287-297.
76. Twycross R. The risks and benefits of corticosteroids in advanced cancer. Drug Safety 1994, 11:163-178.
77. Abram S.E. Neural blockade for neuropathic pain. Clin J Pain 2000, 16:S56-S61.
78. Johansson A., Bennett G.J. Effect of local methylprednisolone on pain in a nerve injury model. A pilot study. Reg Anesth 1997, 22:59-65.
79. Williams J.E. Nerve blocks - chemical and neurolytic agents. Clinical pain management. Cancer pain 2003, 235-244. Oxford University Press, New York. N. Sykes, M.T. Fallon, R.B. Patt (Eds.).
80. Malik K., Benzon H.T. Radiofrequency applications to dorsal root ganglia: a literature review. Anesthesiology 2008, 109:527-542.
81. Cahana A., Van Zundert J., Macrea L., et al. Pulsed radiofrequency: current clinical and biological literature available. Pain Med 2006, 7:411-423.
82. Zeldin A., Ioscovich A. Pulsed radiofrequency for metastatic pain treatment. Pain Physician 2008, 11:921-922.
83. Shapshay S.M., Scott R.M., McCann C.F., Stoelting I. Pain control in advanced and recurrent head and neck cancer. Otolaryngol Clin North Am 1980, 13:551-560.
84. Swerdlow M. Intrathecal neurolysis. Anaesthesia 1978, 33:733.
85. Finnegan C., Saaravanakumar K., Sharma M., Nash T., Corcoran G.D., Hugel H. The role of epidural phenol in cancer patients at the end of life. Palliat Med 2008, 22:777-778.
86. Slatkin N.E., Rhiner M. Phenol saddle blocks for intractable pain at the end of life: report of four cases and literature review. Am J Hosp Palliat Care 2003, 20:62-66.
87. Ischia S., Luzzani A., Ischia A., et al. Subarachnoid neurolytic block (L5-S1) and unilateral percutaneous cervical cordotomy in the treatment of pain secondary to pelvic malignant disease. Pain 1984, 20:139.
88. Candido K.D., Philip C.N., Ghaly R.F., Knezevic N.N. Transforaminal 5% phenol neurolysis for the treatment of intractable cancer pain. Anesth Analg 2010, 110:216-219.
89. Sanders M., Zuurmond W. Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients. J Clin Oncol 1995, 13:1509-1512.
90. Raslan A.M. Percutaneous computed tomography-guided transdiscal low cervical cordotomy for cancer pain as a method to avoid sleep apnea. Stereotact Funct Neurosurg 2005, 83(4):159-164.
91. Jackson M.B., Pounder D., Price C., Matthews A.W., Neville E. Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma. Thorax 1999, 54:238-241.
92. Crul B.J., Blok L.M., van Egmond J., van Dongen R.T.M. The present role of percutaneous cervical cordotomy for the treatment of cancer pain. J Headaches Pain 2005, 6(1):24-29.
93. Sheahy C.N., Mortimer J.T., Reswick J.B. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg 1967, 46:489-491.
94. Stannard C. Stimulation produced analgesia in cancer pain management. Clinical pain management: cancer pain 2003, 245-351. Edward Arnold, London. N. Sykes, M.T. Fallon, R.B. Patt (Eds.).
95. Yakovlev A.E., Ellias Y. Spinal cord stimulation as a treatment option for intractable neuropathic cancer pain. Clin Med Res 2008, 6:103-106.
96. Yakovlev A.E., Resch B.E., Karasev S.A. Treatment of cancer-related chest wall pain using spinal cord stimulation. Am J Hospice Palliat Med 2010, 27(8):552-556.
97. De Leon-Casasola O.A. Critical evaluation of chemical neurolysis of the sympathetic axis for cancer pain. Cancer Control 2000, 7(2):142-148.
98. Raj P.P., Sahinler B., Lowe M. Radiofrequency lesioning of splanchnic nerves. Pain Pract 2002, 2(3):241-247.
99. Eisenberg E., Carr D.B., Chalmers T.C. Neurolytic coeliac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995, 80:290-295.
100. Noble M., Gress F.G. Techniques and results of neurolysis for chronic pancreatitis and pancreatic cancer pain. Curr Gastroenterol Rep 2006, 8(2):99-103.
101. Ischia S., Ischia A., Polati E., et al. Three posterior percutaneous celiac plexus block techniques: a prospective randomized study in 61 patients with pancreatic cancer pain. Anesthesiology 1992, 76:534-540.
102. Puli S.R., Reddy J.B., Bechtold M.L., Antillon M.R., Brugge W.R. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci 2009, 54:2330-2337.
103. Kaufman M., Singh G., Das S., et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol 2010, 44(2):127-134.
104. Perello A., Ashford N.S., Dolin S.J. Coeliac plexus block using computed tomography guidance. Palliat Med 1999, 13(5):419-425.
105. Wong G.Y., Schroeder D.R., Carns P.E., et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004, 291:1092-1099.
106. Mercadante S. Celiac plexus block versus analgesics in pancreatic cancer pain. Pain 1993, 52:187-192.
107. de Oliveira R., dos Reis M.P., Prado W.A. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain 2004, 110:400-408.
108. Davies D.D. Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med 1993, 86:264.
109. Plancarte R., de Leon-Casasola O.A., El-Helaly M., et al. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth 1997, 22:562-568.
110. De Leon-Casasola O., Kent E., Lema M. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain 1993, 54:145-151.
111. Rosenberg S.K., Tewari R., Boswell M.V., et al. Superior hypogastric plexus block successfully treats severe penile pain after transurethral resection of the prostate. Reg Anesth Pain Med 1998, 23:618-620.
112. Wilsey C., Ashford N.S., Dolin S.J. Presacral neurolytic block for relief of pain from pelvic cancer: description and use of a CT-guided lateral approach. Palliat Med 2002, 16(5):441-444.
113. Gupta D., Mishra S., Thulkar S., Bhatnagar S. Ultrasonographic-assisted ganglion impar neurolysis. Anesth Analg 2009, 108:1995-1996.
114. Plancarte R., Amescua C., Patt R.B. Presacral blockade of the ganglion of Walther (ganglion impar). Anesthesiology 1990, 73:A751.
115. Esch A.T., Esch A., Knorr J.L., Boezaart A.P. Long-term ambulatory continuous nerve blocks for terminally ill patients: a case series. Pain Med 2010, 11:1299-1302.
116. Myers D.P., Lema M.J., de Leon-Casasola O.A., Bacon D.R. Interpleural analgesia for the treatment of severe cancer pain in terminally ill patients. J Pain Symptom Manage 1993, 8:505.
117. Amesbury B., O'Riordan J., Dolin S. The use of interpleural analgesia using bupivacaine for pain relief in advanced cancer. Palliat Med 1999, 13:153-158.
118. Wong F.C.S., Lee T.W., Yuen K.K., et al. Intercostal nerve blockade for cancer pain: effectiveness and selection of patients. Hong Kong Med J 2007, 13:266-270.
119. Doyle D. Nerve blocks in advanced cancer. Practitioner 1982, 226:539-544.
120. Ramamurthy S., Walsh N.E., Schoenfeld L.S., Hoffman J. Evaluation of neurolytic blocks using phenol and cryogenic block in the management of chronic pain. J Pain Sympt Manage 1989, 4(2):72-75.
121. Han S.C., Harrison P. Myofascial pain syndrome and trigger-point management. Reg Anesth 1997, 22:89-101.
122. Lee H., Schmidt K., Ernst E. Acupuncture for the relief of cancer-related pain: a systematic review. Eur J Pain 2005, 9(4):437-444.
123. Rowell N.P. Intralesional methylprednisolone for rib metastases: an alternative to radiotherapy?. Palliat Med 1988, 2:153-155.
124. Rousseff R.T., Simeonov S. Intralesional treatment in painful rib metastases. Palliat Med 2004, 18:259.
125. Gangi A., Kastler B., Klinkert A., Dietemann J. Injection of alcohol into bone metastases under CT guidance. J Comput Assist Tomography 1994, 18:932-935.
126. Munk P.L., Rashid F., Heran M.K., et al. Combined cementoplasty and radiofrequency ablation in the treatment of painful neoplastic lesions of bone. J Vasc Interven Radiol 2009, 20:903-911.
127. Thanos L., Mylona S., Galani P., et al. Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol 2008, 37(3):189-194.
128. Twycross R. Pain relief in advanced cancer 1994, Churchill Livingstone, Edinburgh, p. 511.
129. Peh W.C., Munk P.L., Rashid F., Gilula L.A. Percutaneous vertebral augmentation: vertebroplasty, kyphoplasty and skyphoplasty. Radiol Clin North Am 2008, 46:611-635.
130. Burton A.W., Reddy S.K., Shah H.N., Tremont-Lukas I., Mendel E. Percutaneous vertebroplasty, a technique to treat refractory spinal pain in the setting of advanced metastatic cancer: a case series. J Pain Symptom Manage 2005, 30:87-95.
131. Anselmetti G.C., Corrao G., Monica P.D., et al. Pain relief following percutaneous vertebroplasty: results of a series of 283 consecutive patients treated in a single institution. Cardiovasc Intervent Radiol 2007, 30(3):441-447.
132. Hulme P.A., Krebs J., Ferguson S.J., Berleman U. Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies. Spine 2006, 31(17):1983-2001.
133. Fourney D.R., Schomer D.F., Nader R., et al. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 2003, 98:21-30.
134. Gangi A., Guth S., Imbert J., et al. Percutaneous vertebroplasty: indications, technique and results. Radiographics 2003, 23:10.
135. Breivik H. The future role of the anaesthesiologist in pain management. Acta Anaesthesiol Scand 2005, 49(7):922-926.